...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Potential market
6
Nov 17, 2019 02:41AM
4
Nov 17, 2019 03:49AM
6
Nov 17, 2019 02:41PM
5
Nov 17, 2019 02:51PM
4
Nov 17, 2019 03:25PM

Cityslicker ... thatt makes sense. And per our conversation:

 

China: 100,000,000 diabetics (estimated) and growing

India: 85,000,000 diabetics (estimated) and growing

10% with eGFR<60 (estimated)

185,000,000 x 10% = 18,500,000 potential diabetics with eGFR<60

18,500,000 x 25% = 4,625,000 potential diabetics with eGFR<60

Apabetalone cost per patient/annum = $1500.00 (arbitrary estimate)

 

Therefore:  Rough guesstimate of market potential for China/India combined if P=0.06 is acceptable for diabetics with eGFR<60 for significant RRR:

   >>> Between $6,937,500,000 to $27,750,000,000 in annual sales potentially

 

For one intial indication, with no Cognitive marketability factored in, that is a VERY fast "ROI" (potentially) for a BP on a $5-10b purchase, or even a $15+ billion purchase potentially ..... with years of patent protection ahead, and the IP (& other molecules?) for further indications and compound development. 

The conversations with BP's must be very interesting.

3
Nov 17, 2019 03:52PM
4
Nov 17, 2019 03:55PM
9
Nov 17, 2019 04:11PM
9
Nov 17, 2019 05:28PM
4
Nov 18, 2019 03:21AM
Share
New Message
Please login to post a reply